Sp537
GASTROINTESTINAL MOTILITY
Date
May 7, 2023
Explore related products in the following collection:
Tracks
Related Products
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
THE COLONIC BIOLOGICAL CLOCK AND PREDICTABILITY OF TIME OF BOWEL MOVEMENTS DURING TREATMENT WITH A VIBRATING CAPSULE (VIBRANT®) IN PATIENTS WITH SEVERE CHRONIC IDIOPATHIC CONSTIPATION
BACKGROUND: The gastrointestinal (GI) disturbance is a frequent complication in patients with thoracolumbar vertebral fracture (TVF), especially in the postoperative period. Laxatives are sometimes of limited effect…